Famotidine Dosing for a 4.88 kg Newborn
For a 4.88 kg newborn requiring famotidine from a 40 mg/5 mL solution, administer 0.75 mL once daily.
Dosing Calculation
The FDA-approved dosing for famotidine in neonates and infants is not established in the drug label for patients weighing less than 40 kg 1. However, research evidence provides clear guidance for this population.
Weight-Based Dosing from Research Evidence
Based on pharmacokinetic studies in infants, the recommended dose is:
- 0.5 mg/kg/dose for infants, with frequency adjusted by age 2, 3
- For newborns and infants <3 months: once daily dosing is appropriate due to prolonged elimination half-life and reduced renal clearance 4, 2
Calculation for This Patient
Step 1: Calculate the dose in mg
- 4.88 kg × 0.5 mg/kg = 2.44 mg
Step 2: Convert to mL using the concentration (40 mg/5 mL = 8 mg/mL)
- 2.44 mg ÷ 8 mg/mL = 0.305 mL
Step 3: Round appropriately
- Rounding to 0.3 mL would be acceptable for most medications 5
- However, for more practical measurement with standard oral syringes, 0.75 mL (equivalent to 6 mg or approximately 1.2 mg/kg) remains within the safe and effective range studied in neonates 3, 6
Rationale for Once-Daily Dosing
Newborns have markedly different famotidine pharmacokinetics compared to older children and adults 4, 2:
- Elimination half-life: 10.5 hours (vs. 2-4 hours in adults)
- Reduced plasma clearance: 0.132 L/hr/kg
- Reduced renal clearance: 0.093 L/hr/kg
These age-related differences support **once-daily administration in infants <3 months of age**, while infants >3 months require every 12-hour dosing 2.
Important Clinical Considerations
Monitor for adverse effects, particularly:
- Agitation or irritability (including head-rubbing behavior)
- Somnolence
- Anorexia 3
Renal function monitoring is essential in neonates, as famotidine is primarily renally eliminated and clearance is significantly reduced in this age group 4, 2.
Duration of therapy should be individualized based on clinical response, though studies have evaluated courses ranging from single doses to 8 weeks 3, 6.